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Abstract: There is a great need for quantitative outcomes reflecting the functional status in patients
with knee or hip osteoarthritis (OA) to advance the development and investigation of interventions for
OA. The purpose of this study was to determine if gait kinematics specific to the disease—i.e., knee
versus hip OA—can be identified using wearable sensors and statistical parametric mapping (SPM)
and whether disease-related gait deviations are associated with patient reported outcome measures.
113 participants (N = 29 unilateral knee OA; N = 30 unilateral hip OA; N = 54 age-matched asymp-
tomatic persons) completed gait analysis with wearable sensors and the Knee/Hip Osteoarthritis
Outcome Score (KOOS/HOOS). Data were analyzed using SPM. Knee and hip kinematics differed
between patients with knee OA and patients with hip OA (up to 14◦, p < 0.001 for knee and 8◦,
p = 0.003 for hip kinematics), and differences from controls were more pronounced in the affected
than unaffected leg of patients. The observed deviations in ankle, knee and hip kinematic trajectories
from controls were associated with KOOS/HOOS in both groups. Capturing gait kinematics using
wearables has a large potential for application as outcome in clinical trials and for monitoring treat-
ment success in patients with knee or hip OA and in large cohorts representing a major advancement
in research on musculoskeletal diseases.
Keywords: inertial measurement unit; walking; joint motion; gait pattern; function; pain; SPM;
HOOS; KOOS
1. Introduction
Knee and hip osteoarthritis (OA) are very common degenerative joint diseases that will
affect up to 25% of the population during a lifetime [1]. Yet, to date, diagnostics for early OA
are lacking and its treatment focuses primarily on alleviating symptoms. The development
and investigation of interventions such as pharmaceutics is challenging as clinical trials
currently rely on patients reported outcome measures (PROMs) that are subjective, fail to
discriminate good from very good condition (low ceiling effect) [2] or are mostly influenced
by pain and do not reflect function [3]. Other potential outcomes are objective but have
insufficient sensitivity for detecting short term changes (e.g., medical imaging) [4]. Hence,
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there is a great need for quantitative outcomes that reflect the functional status in patients
with knee or hip OA.
The potential of gait analysis in understanding the OA disease process [5]—especially
of knee OA [6–11]—and its treatment [5,12–15] has long been recognized. While the
literature has largely focused on ambulatory load in the context of knee OA [16], differences
in joint motion during walking between patients with (knee or hip) OA and controls
have also been observed [5] although reported data are available primarily for the index
joint [14,17]. Traditionally, ambulatory loading and joint motion is assessed in dedicated
laboratories limiting the application in large scale clinical trials or routine clinical practice.
The feasibility of using gait parameters as functional outcome parameters for clinical trials
necessitates their simple measurement and specificity to the affected joint.
Technological advancements in recent years produced wearable systems based on
inertial measurement units (IMUs) that allow measuring joint kinematics during walking
with a major advantage of facilitating assessments within less than 10 min in settings
outside of the laboratory such as in outpatient clinics. To date, only few studies have
explored their potential for assessing joint kinematics in patients with OA. For instance, for
patients with knee OA, differences in stride duration, knee flexion range of motion (ROM) in
swing and stance have been assessed using the GaitWalk system [18], kinematic differences
at the hip, knee and ankle in the sagittal plane using the H-Gait system [19], and thigh and
shank sagittal and coronal, knee sagittal kinematics as well as temporal gait parameters
using the GaitSmartTM system [20]. In a series of studies, Ismailidis et al. have shown that
known differences in joint kinematics between patients with knee OA [21] or patients with
hip OA [22] and healthy controls can be measured using the RehaGait® system, reported
kinematic differences not only for the index joint but also to adjacent joints, and confirmed
that some of these differences depend on walking speed [23,24].
Lebleu et al. [25] have shown that the limited hip range of motion during walking in
patients with knee OA measured using the XSens system can be increased by an interven-
tion, specifically by genicular nerve blockade, supporting the relevance of gait kinematics
as a potential quantifiable outcome. Moreover, initial attempts for gait classification for
distinguishing patients after hip arthroplasty from healthy controls based on inertial sensor
gait kinematics yielded promising results [26]. However, to date there is little evidence on
differences in gait patterns in patients with OA and healthy controls depending on whether
the knee or the hip is affected [27] and whether this joint specificity can be detected using
inertial sensor systems.
Differences in gait patterns can be assessed by considering discrete parameters (e.g.,
joint angle at initial contact, maximum or minimum joint angles or range of motion) or
the entire joint angle trajectories. Statistical parametric mapping (SPM) is a method for
examining differences in kinematic trajectories where hypotheses expressed in terms of the
model parameters are assessed at each time point with univariate statistics [28]. Because
many statistical tests are conducted, adjustments must be made to control for type I errors
(false positives) potentially caused by the comparison of joint angles over many time points.
The purpose of this study was to determine if gait kinematics specific to the
disease—i.e., knee versus hip OA—can be identified using wearable sensors and SPM and
whether disease-related gait deviations are associated with PROMs. We hypothesized that
the largest sagittal plane kinematic deviations from asymptomatic controls occur at the
index joint with smaller deviations at adjacent joints and joints of the contralateral leg and




Overall, data of 113 participants were included in the analysis. Of these, 29 had
unilateral knee OA and were scheduled to undergo total knee arthroplasty, 30 had unilateral
hip OA and were scheduled total hip arthroplasty, and 54 were age-matched asymptomatic
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persons (Table 1). Subsets of data have been published previously in studies focusing on
differences in gait kinematics between limbs in patients with knee OA and compared to
healthy controls [21,23] and on differences in gait kinematics between limbs in patients with
hip OA and compared to healthy controls [22,24]. For the current analysis, we expanded
all groups of participants and focused on detecting differences in joint kinematics between
patients with knee OA and patients with hip OA.
Table 1. Demographics of patients with knee OA, patients with hip OA and asymptomatic controls.
Values for personal parameters are shown as mean (1 standard deviation).





N 29 30 54
Sex (female/male) 16/13 18/12 23/31
Age (years) 67.2 (8.5) 64.9 (11.6) 66.4 (7.9)
Body height (m) 1.70 (0.10) 1.72 (0.08) 1.70 (0.09)
Body mass (kg) 80.6 (14.4) 1 80.6 (12.8) 1 73.1 (13.5)
Body mass index (kg/m2) 27.9 (3.9) 1 27.1 (3.1) 1 25.3 (4.0)
KOOS
Symptoms 50.1 (19.9) 1 95.4 (6.1)
Pain 47.5 (17.7) 1 97.6 (3.9)
ADL 52.5 (21.9) 1 98.2 (3.0)
Sport/rec 28.2 (19.8) 1 94.9 (9.1)
QOL 25.6 (19.0) 1 95.5 (8.8)
HOOS
Symptoms 48.3 (16.8) 1 96.9 (5.6)
Pain 50.9 (14.9) 1 98.2 (4.4)
ADL 53.9 (17.3) 1 98.6 (3.5)
Sport/rec 36.1 (20.0) 1 98.0 (5.0)
QOL 27.8 (16.4) 1 97.3 (7.2)
1 significantly different from controls (t-tests, p < 0.05/3). OA—osteoarthritis; KOOS—knee osteoarthritis outcome
score; HOOS—hip osteoarthritis outcome score; a normalized score (100 indicating no symptoms and 0 indicating
extreme symptoms) is calculated for each subscale; ADL—function in activities of daily living; sport/rec—function
in sport and recreation; QOL—knee/hip related quality of life.
Patients were recruited from our hospital and from local orthopedic clinics. Inclusion
and exclusion criteria for all groups are listed in Table 2. All subjects gave written informed
consent prior to participation. This study was approved by the regional review board and
conducted in accordance with the Declaration of Helsinki.
Table 2. Inclusion and exclusion criteria.
Criteria Patients with Knee OA Patients with Hip OA Asymptomatic Controls
Inclusion
criteria


























or history of knee or
hip trauma or pain
at the time of the
measurement
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Table 2. Cont.
Criteria Patients with Knee OA Patients with Hip OA Asymptomatic Controls
Exclusion
criteria
• BMI > 35 kg/m2




• Current pain of the
lower back





• BMI > 35 kg/m2




• Current pain of the
lower back





• BMI > 35 kg/m2




• Current pain of the
lower back





• KOOS or HOOS <90
in the pain
subcategory
OA—osteoarthritis; BMI—body mass index; KOOS—knee osteoarthritis outcome score; HOOS—hip osteoarthritis
outcome score.
2.2. Demographic and Clinical Evaluation
Demographic data including age, sex, body mass, body height, and BMI were recorded
for each subject. The subjective severity of the OA was assessed using the PROMs
KOOS [29] respective the HOOS [30]. Patients with knee OA completed the KOOS, pa-
tients with hip OA the HOOS, and asymptomatic controls both the KOOS and the HOOS.
Both tools comprise a total of 40 questions further divided in five subscales consisting
of 9/10 questions for pain (KOOS/HOOS Pain), 7/5 for symptoms (KOOS/HOOS Symp-
toms), 17 for activities of daily living (KOOS/HOOS ADL), 5/4 for sport and recreation
(KOOS/HOOS Sport/Rec) and 4 for knee/hip related quality of life (KOOS/HOOS QOL).
A total score is calculated for each subcategory with a range from 0 to 100, higher scores
representing better conditions. Anteroposterior knee/pelvic X-rays and axial hip X-rays
were used to determine the K/L radiographic severity scale of the affected joint of pa-
tients [31]. A K/L grade of 1 on the contralateral hip was accepted if it was asymptomatic.
The combination of a K/L Grade 3 or 4 and symptoms leading to the decision to perform a
TKA/THA was defined as severe knee/hip OA.
2.3. Gait Analysis
Gait analysis was performed using the RehaGait® (Hasomed, Magdeburg, Germany)
inertial sensor system as described by Nüesch et al. [32]. The system consists of seven sen-
sors (dimensions: 60 mm × 15 mm × 35 mm). Each sensor houses a triaxial accelerometer,
gyroscopes and magnetometer (magnetometer data not used in the proprietary software
computations). Elastic Velcro straps were used to attach the sensors bilaterally to the lateral
foot, lateral lower leg and lateral thigh, and one on the pelvis overlying the 5th lumbar
vertebra. For the calibration of the system, participants were asked to stand still for 10 s and
then flex the trunk and each hip alternatingly. Sensor data were collected while participants
performed a single trial of walking for 20 m at a self-selected speed along a well-lit flat
hallway. During this trial, each participant took approximately 15 steps per side.
The spatiotemporal parameters (walking speed, cadence, stride length, stride duration,
duration of stance/swing phase and single/double support phase as percentage of the gait
cycle) as well as bilateral sagittal plane joint kinematics of the ankle, knee and hip including
gait events (e.g., heel strike) were computed using the manufacturer’s proprietary software
(Hasomed, Magdeburg, Germany) according to Seel et al. [33]. This process entails the
following steps: (1) identification of the joint axis coordinates; (2) matching signs of the
joint axis coordinates; (3) identification of the joint position coordinates; and (4) computing
joint angle from accelerometer and gyroscope readings [33]. The impact of the heel with
the ground during each gait cycle results in a peak of the jerk in the vertical direction [34].
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This peak is detected and defines initial contact or heel-strike. At the end of the stance, the
motion of the foot relative to the ground is characterized by a distinct change in angular
velocity of the foot. This change in angular velocity marks the end of the stance and is used
to define toe-off [34].
Bilateral sagittal plane joint kinematics of the ankle, knee and hip including gait events
were exported as .csv files. Previous studies have shown good agreement of kinematic
parameters with camera-based motion analysis [32], excellent agreement of spatiotemporal
parameters with an instrumented treadmill [35,36], and good to excellent reliability in
healthy subjects [31,34,35].
2.4. Data Processing
Ankle, knee and hip kinematic trajectories were normalized from one heel-strike to
the subsequent ipsilateral heel-strike to obtain time normalized kinematic trajectories. The
first and last two steps of a trial were excluded resulting in data for, on average, 10 steps
per leg and participant.
Kinematic trajectories were time normalized to one gait cycle from heel-strike of
one foot to the subsequent heel-strike of the same foot. Dynamic joint range of motion
(ROM), minimum and maximum ankle, knee and hip angles during stance and swing were
computed using a custom algorithm written in Matlab (MathWorks Inc., Natick, MA, USA)
from the time normalized kinematic trajectories for each stride. Average trajectories across
all trials for each leg and each participant were computed and used for further analyses.
Mean and standard deviation (SD) kinematic trajectories for ankle, knee and hip
angles were computed for each group g, joint j and side s from the time normalized















where t is time normalized to one gait cycle, p is the participant number, N the number
of participants in group g and side s affected or unaffected in patients and left or right in
controls, respectively (affected side of patients was matched with left side of controls, and
unaffected side of patients was matched with right side of controls).
Deviations from the mean of the control group were computed for the affected side of
each patient p, joint j and time point t as
∆anglej,p(t) = anglej,p(t)− meanj,controls, le f t(t) (3)
2.5. Statistical Analyses
The required number of subjects was calculated based on group differences in discrete
parameters reported in the literature [16,37] and based on previous comparisons between
patients with knee OA [21] or patients with hip OA [22] versus asymptomatic controls.
Sample size estimation revealed that 14 participants were required to detect an expected
difference in knee ROM with an effect size of at least 1.12 with 80% power at a 5% signifi-
cance level. Because it was expected that SPM is at least as sensitive in detecting differences
between groups as 0-dimensional methods, we deemed the available dataset as sufficient
for the planned analyses.
Because all demographic parameters were normally distributed, analysis of variance
(ANOVA) with independent sample t-tests as posthoc tests were performed to detect statis-
tically significant group differences in demographic parameters, and parametric descriptive
statistics included mean and standard deviation for each group. The significance level was
set a priori to 0.05 for the ANOVA and to 0.05/3 for posthoc tests with Bonferroni adjust-
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ment. Mean and standard deviations for discrete ankle, knee and hip kinematic parameters
were computed and are presented in Table S1 to facilitate comparison to the literature.
For the kinematic trajectories, we tested the null hypothesis that there are no differ-
ences in 1D kinematic data between patients with knee OA, patients with hip OA and
asymptomatic control subjects. We examined the entire time normalized mean kinematic
trajectories using SPM. All SPM analyses were conducted in Matlab (MathWorks Inc.,
Natick, MA, USA) using the opensource software package spm1D 0.4 (www.spm1d.org;
accessed on 15 January 2021) [28]. Between-group statistical analyses were conducted
as described by Pataky [28]. Briefly, an ANOVA was performed for each joint to detect
an overall group effect. Independent sample t-tests were performed to compare pairs
of groups in a posthoc analysis. The null hypothesis was rejected if the experimentally
computed t-value for trajectory 1D data exceeded the critical value that was calculated
based on Gaussian random field theory. The significance level was set to 0.05 for the
ANOVA of the SPM analysis and to 0.05/3 for the posthoc t-tests for independent samples
with Bonferroni adjustment.
Statistically significant associations between KOOS and HOOS subscores and kine-
matic trajectories among patients with knee OA and controls and among patients with hip
OA and controls, respectively, were evaluated through scalar trajectory linear regression
tests [38] (documented in www.spm1D.org, v0.4, accessed on 1 August 2021). The anal-
yses were conducted for each joint separately. For each SPM analysis, the t statistic was
computed at each point in the time series. We visualized the results as mean ±1 standard
deviation of the joint angles (vertical axis) time-normalized to one gait cycle), SPM statistic
(vertical axis) time-normalized to one gait cycle and mean difference in joint angles between
groups (vertical axis) time-normalized to one gait cycle. To allow for the visualization of
group differences in the context of variability in joint angles in the control group, we also
included ±1 standard deviation of the joint angles of the control group across the gait cycle
in the mean difference in joint angle graphs. The significance level was set a priori to 0.05.
3. Results
Descriptive statistics for spatiotemporal parameters and 95% confidence intervals for
differences between groups are given in Table S1.
3.1. Overall Group Effect in Joint Kinematics
SPM with ANOVA revealed statistically significant differences in ankle, knee and hip
kinematic trajectories between the affected/left side of all groups for most of the gait cycle
(Figure 1). Ankle dorsiflexion differed between groups during midstance and terminal
stance with no significant differences during early stance and swing. Knee flexion differed
between groups for the entire stance phase and the first half of swing. Hip flexion differed
between groups for the entire gait cycle except during the first half of swing. Descriptive
statistics of selected discrete ankle, knee and hip kinematic parameters and 95% confidence
intervals for differences between groups are given in Table S1.
Fewer differences in knee and hip kinematic trajectories were observed between the
unaffected/right side of all groups (Figure S1). Knee flexion differed between groups only
during the first half of swing. Hip flexion differed between groups only during terminal
stance and pre-swing.







Figure 1. Comparison between all participant groups. (a) Mean and 1 standard deviation joint angle
trajectories for ankle dorsiflexion (left), knee flexion (center) and hip flexion (right) angle for the
affected/left leg for patients with knee OA (blue), patients with hip OA (green) and controls (black);
(b) results of statistical parametric mapping with analysis of variance (SPM{F}) where regions with
statistically significant difference between all groups are indicated as grey regions (p < 0.05).
3.2. Patients with OA Versus Controls
Ankle, knee and hip kinematic trajectories for patients with knee OA and controls
are shown in Figure 2. Main kinematic differences between the affected leg in patients
with knee OA and controls were greater ankle dorsiflexion during midstance, terminal
stance and pre-swing (+12◦, p < 0.001), less knee flexion during weight acceptance (−7◦,
p < 0.001) and in the first half of swing (−13◦, p < 0.001) and less hip extension during
terminal stance (−4◦, p = 0.002). Kinematic differences between the contralateral leg in
patients with knee OA and controls included greater ankle dorsiflexion during midstance
through early swing (+13◦, p < 0.001), less knee flexion during early swing (−13◦, p < 0.001)
and less hip extension during terminal stance (−5◦, p < 0.001; Figure S2). The reported
differences in brackets are maximum angles in the areas that have significant differences
between different groups.
In patients with hip OA, differences in ankle dorsiflexion from controls were not
statistically significant (Figure 3). Main kinematic differences between the affected leg in
patients with hip OA and controls were greater knee flexion during terminal stance (+8◦,
p < 0.001), less hip flexion during weight acceptance and late swing (−8◦, p < 0.001) and
less hip extension during mid- to terminal stance (−3◦, p = 0.010; Figure 3). Kinematic
differences between the contralateral leg in patients with hip OA and controls included
greater ankle dorsiflexion during pre- and early swing (+9◦, p < 0.001), no differences at
the knee and less hip extension during terminal stance (−3◦, p = 0.002; Figure S3). The
reported differences in brackets are maximum angles in the areas that have significant
differences between different groups.







Figure 2. Comparison between patients with knee OA and controls. (a) Mean and 1 standard
deviation joint angle trajectories for ankle dorsiflexion (left), knee flexion (center) and hip flexion
(right) angle for the affected/left leg for patients with knee OA (blue) and controls (black); (b) results
of statistical parametric mapping with posthoc t tests (SPM{t}) where regions with statistically
significant difference between groups are indicated as grey regions (p < 0.05/3); (c) mean joint angle
deviation from the control group for patients with knee OA where grey areas illustrate ±1 SD of the







Figure 3. Comparison between patients with hip OA and controls. (a) Mean and 1 standard deviation
joint angle trajectories for ankle dorsiflexion (left), knee flexion (center) and hip flexion (right)
angle for the affected/left leg for patients with hip OA (green) and controls (black); (b) results of
statistical parametric mapping with posthoc t tests (SPM{t}) where regions with statistically significant
difference between groups are indicated as grey regions (p < 0.05/3); (c) mean joint angle deviation
from the control group for patients with hip OA where grey areas illustrate ±1 SD of the joint angles
of the control group.
3.3. Patients with Hip OA Versus Patients with Knee OA
Differences in ankle dorsiflexion between patients with hip OA and patients with knee
OA were not statistically significant (Figure 4). Main kinematic differences between the
affected leg in patients with hip OA and patients with knee OA were greater knee flexion
during midstance, terminal stance and pre-swing (+14◦, p < 0.001) and less hip extension
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during late swing (−8◦, p = 0.003) and initial contact (−6◦, p = 0.015; Figure 4). Kinematic
trajectories for the contralateral ankles, knees and hips did not differ significantly between
patients with hip OA and patients with knee OA (Figure S4). The reported differences









Figure 4. Comparison between patients with knee OA and patients with hip. (a) Mean and 1 standard
deviation joint angle trajectories for ankle dorsiflexion (left), knee flexion (center) and hip flexion
(right) angle for the affected leg for patients with knee OA (blue) and patients with hip OA (green);
(b) results of statistical parametric mapping with posthoc t tests (SPM{t}) where regions with statisti-
cally significant difference between groups are indicated as grey regions (p < 0.05/3); (c) mean joint
angle deviation from patients with knee OA for patients with hip OA where grey areas illustrate
±1 SD of the joint angles of the control group.
3.4. Association between Gait Deviations from Controls and PROMs
3.4.1. Knee OA
The association between KOOS subscores and kinematic trajectories among patients
with knee OA and controls were significant for ankle dorsiflexion during midstance,
terminal stance and pre-swing knee flexion during weight acceptance and in the first half
of swing and hip flexion during terminal stance (Figures 5 and S5). These regions coincided
with regions where significant differences in kinematic trajectories between patients with
knee OA and controls were observed (Figure 2).
3.4.2. Hip OA
The association between HOOS subscores and kinematic trajectories among patients
with hip OA and controls were significant for ankle dorsiflexion during terminal stance
(HOOS symptoms and HOOS QOL only) and early swing (HOOS symptoms, HOOS pain,
HOOS ADL and HOOS QOL), knee flexion during terminal stance and hip flexion during
weight acceptance, midstance (except HOOS sport/rec) and late swing (Figures 6 and S6).
Except for the ankle, these regions coincided mostly with regions where significant
differences in kinematic trajectories between patients with hip OA and controls were
observed (Figure 3).







5 Figure 5. Association between KOOS subscores and kinematic trajectories. Results of statistical para-
metric mapping with regression analysis (SPM{t}) are shown for (a) the KOOS subscore symptoms
and (b) the KOOS subscore pain and the ankle (left), knee (center) and hip (right) of the affected/left
leg where grey areas illustrate regions with statistically significant relationships between KOOS
subscores and kinematics (p < 0.05). 
3 
 
Figure 6. Association between HOOS subscores and kinematic trajectories. Results of statistical para-
metric mapping with regression analysis (SPM{t}) are shown for (a) the HOOS subscore symptoms
and (b) the HOOS subscore pain and the ankle (left), knee (center) and hip (right) of the affected/left
leg where grey areas illustrate regions with statistically significant relationships between HOOS
subscores and kinematics (p < 0.05).
4. Discussion
The purpose of this study was to determine if gait kinematics specific to knee versus
hip OA can be identified using wearable sensors and SPM and whether disease-related
gait deviations are associated with PROMs. We identified clear differences in knee and hip
kinematics between patients with knee OA and patients with hip OA. Moreover, patients
with knee OA showed deviations from controls in ankle, knee and hip kinematic patterns
in their affected leg with fewer deviations in the contralateral leg. Patients with hip OA
showed deviations from control in knee and hip kinematics of the affected with fewer
deviations in the contralateral leg. These results confirm our hypothesis that the largest
kinematic deviations from asymptomatic controls occur at the index joint with smaller
deviations at adjacent joints and joints of the contralateral leg. The observed deviations in
ankle, knee and hip kinematics from controls were associated with PROMs in both groups.
To date, a direct comparison of gait kinematics between patients with knee OA and
patients with hip OA is scarce and limited to discrete gait parameters [27]. A wealth of
evidence on differences in joint kinematics during walking in the index joint of patients with
knee or hip OA compared to healthy controls has been published. According to a systematic
review [16], these differences range between 2.5◦ and 10.9◦ and in some studies up to 23◦
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in patients with knee OA. Main differences include lower knee ROM and peak flexion
during swing and stance, especially in patients with severe knee OA [27,39,40] and smaller
knee flexion-extension ROM over the entire gait cycle [39]. More recently, van der Straaten
et al. [17] reported in a systematic review of the literature on mobile kinematic assessments
that in patients with knee OA, the knee flexion ROM during stance and swing is about 10◦
smaller than that in healthy controls. Surprisingly, few studies have investigated kinematic
differences at the ankle or hip between patients with knee OA and controls [16,27,41,42].
While some studies found no difference in ankle or hip kinematics between patients with
knee OA, others reported smaller ankle ROM, greater ankle dorsiflexion or lower peak hip
extension in patients with severe knee OA [21,27,39,42].
The main reported differences in discrete parameters describing hip kinematics
in patients with hip OA compared to controls include smaller hip flexion ROM with
lower [6,36,40,43] or no differences in peak flexion [27] and lower peak extension [6,36,40,43].
Considering the entire kinematic trajectories, Ardestani et al. [40] and Porta et al. [41] ob-
served smaller hip flexion in early stance and hip extension between 30 and 70% of the
gait cycle. Only a few studies on gait in hip OA reported data for the ankle or knee. Of
these, some reported no significant differences in knee ROM [6], while others described a
reduction in knee flexion ROM [22,27,36,40,44,45] and greater [6,22,45] or comparable [27]
peak ankle dorsiflexion in the affected leg in patients with hip OA compared to controls.
The results of our study regarding deviation in ankle, knee and hip kinematics in
patients with knee OA and in patients with hip OA compared to controls confirm the
literature. Based on the data reported in the literature and presented in this paper for each
group, one would expect similarities between groups in greater peak ankle dorsiflexion
and reduced knee flexion ROM during stance and hip extension during stance. Expected
discrepancies would be greater ankle dorsiflexion ROM, peak knee flexion during stance
and swing, knee flexion ROM during swing and reduced peak hip flexion in patients with
hip OA compared to patients with knee OA. Indeed, the comparison of ankle, knee and hip
kinematics between patients with hip OA and patients with knee OA in our study revealed
no differences in ankle plantar/dorsiflexion between groups and greater knee flexion
during midstance, terminal stance and pre-swing and less hip extension during late swing
and initial contact in patients with hip OA than in patients with knee OA. These results
represent strong evidence for the presence of disease-related gait deviations from controls
that are specific to the affected joint and confirm results of a previous study [27]. Based on
our results it seems feasible that data obtained using wearable gait analysis systems may
contribute to a better understanding of the primary affected site and may be sensitive to
changes in function specific to the affected joint. Based on our clinical experience, many
patients affected by OA also have other ailments such as low back problems (e.g., spinal
stenosis) or are affected at multiple joints. Hence, the potential of wearable data should be
further explored in studies involving patients with degenerative joint disease of varying
severity and different sites.
Deviations in ankle, knee and hip kinematics from controls were associated with
the subscores of the KOOS and HOOS in patients with knee OA and patients with hip
OA, respectively. Interestingly, the associations were significant in those regions of the
kinematic trajectories, where trajectories differed significantly from patterns of the control
group. These results suggest that patients with knee or hip OA with greater subjective
pain, symptoms or functional limitation also have greater deviations in gait patterns from
age-matched controls. Our data support previous reports of the association of mechanical
factors and pain in patients with knee OA using discrete parameters [42] but contradict
results reported by Astephen Wilson et al. [43], who reported no association between
knee flexion angle trajectories (and knee adduction moment) and pain assessed using
principal component analysis. In a more recent study on a very small group of patients,
Bensalma et al. [44] explored the value of different discrete knee kinematic parameters
in explaining differences in pain in patients with knee OA using canonical correlation
analysis and identified groups of parameters that may be of clinical relevance. However,
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these studies only considered ambulatory knee biomechanics and did not consider gait
deviations at other joints. Rosenlund et al. [45] computed the gait deviation index from
nine continuous variables including ankle, knee and hip kinematics and found that patients
with hip OA with greater gait deviation from controls had worse HOOS subscore values.
While the strength of that study is that the kinematics of the entire limb was considered, the
computation obscures the contribution of each of the joints to the gait deviation. Moreover,
Tateuchi et al. [46] showed that limited hip extension during gait is one of the factors that
was related to a deterioration in physical function in patients with hip OA, suggesting that
deviations from kinematics in healthy persons may not only reflect the functional status of
patients but are also valuable for predicting outcome.
All of these studies have in common that gait kinematics were collected using laborato
ry-based motion analysis systems. In our study, we provided first evidence for an associa-
tion of ankle, knee and hip kinematics obtained using wearable sensors and PROMs. In this
study, we chose to explore our data using SPM. While we acknowledge the current large
push—in academia and industry—towards big data approaches for evaluating motion
data using wearables and artificial intelligence, with the current study we would like to
emphasize the importance of considering parameters with a functional, biomechanical
and clinical meaning that capture joint function and biomechanics in the context of dis-
ease development, progression and treatment. The data presented here suggest that joint
kinematics may be a suitable objective and measurable data type that should be explored
further in studies on early OA, diagnostics, clinical exams and as outcomes for clinical
trials on various conservative, surgical or pharmaceutical therapies. Moreover, our data
clearly show the effect of OA in one joint on its adjacent joints, and hence focusing on the
index joint may obscure important functional changes in overall ambulatory biomechanics.
A major strength of this study is the consideration of kinematic trajectories rather than
only discrete parameters allowing to identify the phases of gait with the most relevant
kinematic deviations. This knowledge may be helpful for the therapist or clinician to focus
specifically on these phases during clinical exams without instrumentation. Moreover, in
contrast to most previous studies, we included data on joints adjacent to the index joint.
One of the limitations of this cross-sectional study is that we included only patients with
severe OA awaiting joint replacement surgery and did not investigate the sensitivity of
deviations in ankle, knee and hip kinematics to intervention, which should be explored
in future studies. Although patients with OA had a significantly higher BMI, the mean
differences in BMI between patients and controls were 2.6 kg/m2, and hence we decided not
to account for this discrepancy in our analyses. This factor should be considered in future
trials in large cohorts. Further, while we relied on the manufacturer’s algorithm to compute
kinematic trajectories, previous studies using the same system have produced consistent
and reliable results hence supporting the relevance of the data presented here. Finally, we
limited our analyses to sagittal plane kinematics. Further gait kinematic deviations may
be present in the frontal and transverse planes. These and their association with PROMs
should be further explored in future studies.
5. Conclusions
Known kinematic patterns associated with knee or hip OA can not only be measured
with a wearable inertial sensor system, but these gait alterations are also specific to knee or
hip OA, respectively. Main kinematic differences to asymptomatic control subjects were
observed at the respective index joint with lesser compensation at adjacent joints. These
results point towards the potential of using gait analysis with wearable inertial sensors
to help in the diagnosis of the primary disease site. This study represents an important
step towards future use of kinematic gait parameters as outcome in clinical trials and for
monitoring treatment success in patients with knee or hip OA. Moreover, observed changes
at adjacent joints emphasize the importance of assessing overall kinematic changes to
recognize the potential of developing OA at adjacent or contralateral joints because of com-
pensatory mechanisms. Clearly, capturing gait kinematics using wearables as those utilized
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in this study have a great potential for application in large cohorts, representing a major
advancement in movement science and research on musculoskeletal diseases. Assessing
these data can now be easily implemented in routine clinical practice complementing and
objectifying PROMs.
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